Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions
暂无分享,去创建一个
Yuan Zhang | P. Marsden | K. Thai | A. Advani | R. Gilbert | P. Rakoczy | S. Marshall | D. Kelly | K. White | S. Advani | A. Cox | R. Gow | B. Steer
[1] H. Sugiyama,et al. Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries. , 2006, American journal of hypertension.
[2] F. Puglisi,et al. Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm). , 2006, Critical reviews in oncology/hematology.
[3] A. Hara,et al. Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis. , 2006, Kidney international.
[4] Y. Mori,et al. Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats , 2006, Experimental Neurology.
[5] M. Saint-Geniez,et al. Vascular endothelial growth factor localization in the adult. , 2006, The American journal of pathology.
[6] K. Tryggvason,et al. Heparan sulfate of perlecan is involved in glomerular filtration. , 2005, Journal of the American Society of Nephrology : JASN.
[7] Yuan Zhang,et al. Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.
[8] F. Ziyadeh,et al. Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes. , 2004, Diabetes.
[9] H. Haller,et al. Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. , 2004, Diabetes.
[10] R. Bilous,et al. Estimation of podocyte number: a comparison of methods. , 2004, Kidney international.
[11] J. Wilson. Angiogenesis Therapy Moves beyond Cancer , 2004, Annals of Internal Medicine.
[12] A. Flyvbjerg,et al. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. , 2004, Kidney international.
[13] E. Ritz,et al. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. , 2004, American journal of physiology. Renal physiology.
[14] Seth M Steinberg,et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. , 2003, The New England journal of medicine.
[15] R. Gilbert,et al. Vascular endothelial growth factor expression and glomerular endothelial cell loss in the remnant kidney model. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] R. Kalluri,et al. Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria* , 2003, The Journal of Biological Chemistry.
[17] J. Haigh,et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. , 2003, The Journal of clinical investigation.
[18] T. Libermann,et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia , 2003 .
[19] R. Tilton,et al. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. , 2002, Diabetes.
[20] K. Chan,et al. RET receptor tyrosine kinase isoforms in kidney function and disease , 2002, Oncogene.
[21] G. Jerums,et al. Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] T. Nakagawa,et al. Nitric oxide modulates vascular disease in the remnant kidney model. , 2002, The American journal of pathology.
[23] Renhui Yang,et al. Exaggerated Hypotensive Effect of Vascular Endothelial Growth Factor in Spontaneously Hypertensive Rats , 2002, Hypertension.
[24] S. Wedge,et al. Novel 4-anilinoquinazolines with C-7 basic side chains: design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors. , 2002, Journal of medicinal chemistry.
[25] J. Hughes,et al. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. , 2001, Journal of the American Society of Nephrology : JASN.
[26] Y. G. Kim,et al. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. , 2000, Kidney International.
[27] S. Fleming. Malignant hypertension – the role of the paracrine renin–angiotensin system , 2000, The Journal of pathology.
[28] R. Bilous,et al. Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. , 2000, Journal of the American Society of Nephrology : JASN.
[29] L. Gnudi,et al. Interaction of Angiotensin Ii and Mechanical Stretch on Vascular Endothelial Growth Factor Production by Human Mesangial Cells , 2022 .
[30] G. Remuzzi,et al. Pathophysiology of progressive nephropathies. , 1998, The New England journal of medicine.
[31] David W. Johnson,et al. Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats1 , 1998 .
[32] M. Cooper,et al. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[33] David A. Mankoff,et al. Application of Photoshop-based Image Analysis to Quantification of Hormone Receptor Expression in Breast Cancer , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[34] K. Tomita,et al. Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis. , 1997, The Journal of clinical investigation.
[35] A. Mantovani,et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.
[36] Kenneth J. Hillan,et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene , 1996, Nature.
[37] Janet Rossant,et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.
[38] D. Ganten,et al. Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat. , 1995, Hypertension.
[39] D. Campbell,et al. Angiotensin peptides in spontaneously hypertensive and normotensive Donryu rats. , 1995, Hypertension.
[40] W L Stahl,et al. Fundamentals of quantitative autoradiography by computer densitometry for in situ hybridization, with emphasis on 33P. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[41] G. Jerums,et al. Triphasic Changes in Selectivity with Increasing Proteinuria in Type 1 and Type 2 Diabetes , 1989, Diabetic medicine : a journal of the British Diabetic Association.
[42] R. Atkins,et al. The enhancement of aminonucleoside nephrosis by the co-administration of protamine. , 1987, Kidney international.
[43] H. Dvorak,et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.
[44] R. Buñag. Validation in awake rats of a tail-cuff method for measuring systolic pressure. , 1973, Journal of applied physiology.
[45] E. Weibel,et al. A principle for counting tissue structures on random sections. , 1962, Journal of applied physiology.
[46] A. Flyvbjerg,et al. The effect of intrauterine environment and low glomerular number on the histological changes in diabetic glomerulosclerosis , 2005, Diabetologia.
[47] C. Cohen,et al. Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue. , 2002, Kidney international.